Trevi Therapeutics (TRVI) Operating Leases (2018 - 2026)
Trevi Therapeutics (TRVI) posted quarterly Operating Leases of $364000.0 for Q1 2026, down 46.55% year-over-year from $681000.0 in Q1 2025, and down 18.39% quarter-over-quarter from $446000.0 in Q4 2025.
Trevi Therapeutics (TRVI) Operating Leases (2018 - 2026) Analysis & Trends
Trevi Therapeutics' Operating Leases history runs 9 years deep, the most recent figure standing at $364000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 46.55% year-over-year to $364000.0; the TTM figure through Mar 2026 stood at $364000.0 (down 46.55% YoY), while the FY2025 annual figure was $446000.0, down 40.29% from the prior year.
- Operating Leases for Q1 2026 stood at $364000.0, down from $446000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.1 million in Q1 2023, with the low at $2000.0 in Q3 2022.
- The 5-year median for Operating Leases is $714000.0 (2024), against an average of $645375.0.
- The sharpest annual moves came in 2022 and 2023: Operating Leases slumped 96.7% in 2022, then jumped 52450.0% in 2023.
- Trevi Therapeutics' Operating Leases stood at $2000.0 in 2022, then jumped by 49950.0% to $1.0 million in 2023, then decreased by 25.37% to $747000.0 in 2024, then tumbled by 40.29% to $446000.0 in 2025, then slipped by 18.39% to $364000.0 in 2026.
- Business Quant data shows TRVI's Operating Leases at $364000.0 in Q1 2026, $446000.0 in Q4 2025, and $527000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 276,000.00 |
| Mar 31, 2026 | 364,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 605,000.00 |
| Mar 31, 2025 | 681,000.00 |
| Dec 31, 2024 | 747,000.00 |
| Sep 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 949,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 91,000.00 |